• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素 36RN 和 CARD14 突变与泛发性脓疱型银屑病患者临床表现和实验室检查的相关性。

Correlation of IL36RN and CARD14 mutations with clinical manifestations and laboratory findings in patients with generalised pustular psoriasis.

机构信息

Department of Dermatology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.

Department of Dermatology, Institute of Clinical Research and Medicine, Hanoi, Vietnam.

出版信息

Indian J Dermatol Venereol Leprol. 2023 May-Jun;89(3):378-384. doi: 10.25259/IJDVL_1054_2021.

DOI:10.25259/IJDVL_1054_2021
PMID:36331855
Abstract

Background Generalized pustular psoriasis (GPP) is a chronic disease associated with genetic factors related to mutations of the interleukin 36 receptor antagonist gene (IL36RN) and the caspase recruitment domain 14 gene (CARD14). However, the relevance of these mutations to the clinical features and severity of GPP remains unclear. Aims Our objective was to correlate the presence of IL36RN and CARD14 mutations with the clinical and laboratory findings in patients with GPP. Methods This cross-sectional descriptive study was conducted in 64 subjects with GPP. Clinical manifestations were recorded and the severity was graded as mild, moderate, or severe. Routine laboratory tests were performed and blood samples were collected for Sanger sequencing. The clinical data of patients were compared among the different mutation groups. Results The two main variants of IL36RN were c.115+6T > C (p.Arg10ArgfsX1) and c.227C > T (p.Pro76Leu). The major CARD14 mutations were c.2458C > T (p.Arg820Trp), c.1641C > T (p.Arg547Ser), and c.1753G > A transitions. Provocative factors were uncommon in the group with both IL36RN and CARD14 mutations. Drugs (unspecified), especially herbals, were the most common triggers. A history of psoriasis was frequent in patients with only CARD14 mutations, but fever was uncommon. The c.1641C > T mutation was associated with leukocytosis > 15000/mm3 and the c.1753G > A mutation was associated with hypoalbuminemia <3.8g/dL. Both the c.115+6T > C and c.227C > T variants of IL36RN were associated with fever ≥38.5°C while the c.115+6T > C variant was also associated with geographic tongue. No gene mutations were associated with the total severity and severity grades. Limitations Four patients without the two major IL36RN mutations were excluded from the study. Conclusion The presence of IL36RN and CARD14 mutations were associated with a history of psoriasis, various provocative factors, fever, leukocytosis, hypoalbuminemia, and geographic tongue. Further studies to explore the role of these mutations in therapeutic efficacy and disease outcomes are necessary.

摘要

背景 全身性脓疱型银屑病(GPP)是一种与基因相关的慢性疾病,这些基因与白细胞介素 36 受体拮抗剂基因(IL36RN)和衔接蛋白 14 基因(CARD14)的突变有关。然而,这些突变与 GPP 的临床特征和严重程度的相关性尚不清楚。目的 我们旨在将 IL36RN 和 CARD14 突变的存在与 GPP 患者的临床和实验室发现相关联。方法 这是一项在 64 例 GPP 患者中进行的横断面描述性研究。记录临床表现,并对严重程度进行分级为轻度、中度或重度。进行常规实验室检查,并采集血样进行 Sanger 测序。比较不同突变组患者的临床数据。结果 IL36RN 的两个主要变体为 c.115+6T > C(p.Arg10ArgfsX1)和 c.227C > T(p.Pro76Leu)。CARD14 的主要突变为 c.2458C > T(p.Arg820Trp)、c.1641C > T(p.Arg547Ser)和 c.1753G > A 转换。在同时存在 IL36RN 和 CARD14 突变的组中,诱发因素并不常见。药物(未特指),特别是草药,是最常见的触发因素。仅有 CARD14 突变的患者中常伴有银屑病病史,但发热不常见。c.1641C > T 突变与白细胞计数 > 15000/mm3 有关,c.1753G > A 突变与低白蛋白血症 <3.8g/dL 有关。IL36RN 的 c.115+6T > C 和 c.227C > T 变体均与发热 ≥38.5°C 有关,而 c.115+6T > C 变体还与地图舌有关。两种基因的突变均与总严重程度和严重程度分级无关。局限性 有 4 例没有 IL36RN 两个主要突变的患者被排除在研究之外。结论 IL36RN 和 CARD14 突变的存在与银屑病病史、各种诱发因素、发热、白细胞增多、低白蛋白血症和地图舌有关。需要进一步研究这些突变在治疗效果和疾病结局中的作用。

相似文献

1
Correlation of IL36RN and CARD14 mutations with clinical manifestations and laboratory findings in patients with generalised pustular psoriasis.白细胞介素 36RN 和 CARD14 突变与泛发性脓疱型银屑病患者临床表现和实验室检查的相关性。
Indian J Dermatol Venereol Leprol. 2023 May-Jun;89(3):378-384. doi: 10.25259/IJDVL_1054_2021.
2
The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.泛发性脓疱型银屑病的遗传背景:IL36RN突变和CARD14功能获得性变体。
J Dermatol Sci. 2014 Jun;74(3):187-92. doi: 10.1016/j.jdermsci.2014.02.006. Epub 2014 Mar 5.
3
The genetic basis for most patients with pustular skin disease remains elusive.大多数脓疱性皮肤病患者的遗传基础仍难以捉摸。
Br J Dermatol. 2018 Mar;178(3):740-748. doi: 10.1111/bjd.15867. Epub 2018 Jan 22.
4
Excellent response to secukinumab in an infant with severe generalized pustular psoriasis.婴幼儿严重泛发性脓疱型银屑病应用司库奇尤单抗后获得良好疗效。
J Dermatol. 2021 Jun;48(6):907-910. doi: 10.1111/1346-8138.15673. Epub 2021 Feb 4.
5
Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab.采用全外显子组测序方法对儿童发病家族性红皮病性银屑病进行研究,揭示了 CARD14 的一种新突变,需要使用非常高剂量的乌司奴单抗。
Pediatr Rheumatol Online J. 2019 Jul 8;17(1):38. doi: 10.1186/s12969-019-0336-3.
6
Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis.IL36RN突变与泛发性脓疱型银屑病患者的临床特征、阿维A治疗反应及复发频率的相关性
Eur J Dermatol. 2018 Apr 1;28(2):217-224. doi: 10.1684/ejd.2018.3245.
7
Case of generalized pustular psoriasis with coexisting mutations in IL36RN and CARD14.伴有IL36RN和CARD14基因共存突变的泛发性脓疱型银屑病病例
J Dermatol. 2019 Oct;46(10):e368-e370. doi: 10.1111/1346-8138.14909. Epub 2019 May 7.
8
A viewpoint on the genetic determinants of generalised pustular psoriasis.全身性脓疱型银屑病遗传决定因素的观点。
Exp Dermatol. 2023 Aug;32(8):1188-1193. doi: 10.1111/exd.14746. Epub 2023 Jan 28.
9
Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia.青少年泛发性脓疱型银屑病是一种慢性难治性疾病:对马来西亚柔佛州一家三级医院收治的27例患者的分析。
Int J Dermatol. 2017 Apr;56(4):392-399. doi: 10.1111/ijd.13489. Epub 2017 Feb 14.
10
Mutations in IL36RN are associated with geographic tongue.白细胞介素36受体拮抗剂(IL36RN)基因突变与地图舌有关。
Hum Genet. 2017 Feb;136(2):241-252. doi: 10.1007/s00439-016-1750-y. Epub 2016 Nov 29.

引用本文的文献

1
Epidemiological, Genetic, Clinical, and Treatment Differences of Generalized Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Across Ethnicities: A Systematic Review.泛发性脓疱型银屑病和Hallopeau连续性肢端皮炎在不同种族间的流行病学、遗传学、临床及治疗差异:一项系统综述
Am J Clin Dermatol. 2025 May;26(3):395-409. doi: 10.1007/s40257-025-00937-9. Epub 2025 Apr 1.
2
Analysis of the therapeutic effect of acitretin capsules combined with cooling blood and detoxifying formula on psoriasis hemorrhagic fever and its impact on the gut microbiota of patients.阿维A胶囊联合凉血解毒方治疗银屑病性红皮病的疗效分析及其对患者肠道微生物群的影响
Medicine (Baltimore). 2025 Mar 21;104(12):e41502. doi: 10.1097/MD.0000000000041502.
3
Case report: Efficacy of tofacitinib in the treatment of generalized pustular psoriasis.病例报告:托法替布治疗泛发性脓疱型银屑病的疗效
Front Med (Lausanne). 2025 Feb 17;12:1518583. doi: 10.3389/fmed.2025.1518583. eCollection 2025.
4
Asia-Pacific consensus recommendations on the management of generalized pustular psoriasis.亚太地区泛发性脓疱型银屑病管理共识推荐意见
J Dermatol. 2024 Dec;51(12):1579-1595. doi: 10.1111/1346-8138.17471. Epub 2024 Oct 10.
5
Comparative Efficacy and Safety of Ustekinumab and Secukinumab in the Treatment of Generalized Pustular Psoriasis: A 48-Week Retrospective Cohort Study with Genetic Background Analysis.乌司奴单抗与司库奇尤单抗治疗泛发性脓疱型银屑病的疗效和安全性比较:一项48周的回顾性队列研究及遗传背景分析
J Inflamm Res. 2024 Sep 24;17:6707-6721. doi: 10.2147/JIR.S472338. eCollection 2024.
6
Targeted review of mutations in patients with generalised pustular psoriasis.泛发性脓疱型银屑病患者突变的针对性综述。
Skin Health Dis. 2024 Mar 6;4(2):e343. doi: 10.1002/ski2.343. eCollection 2024 Apr.
7
Pediatric psoriasis: Understanding pathological conditions and advances in treatment.儿童银屑病:了解病理状况和治疗进展。
J Dermatol. 2024 Feb;51(2):185-195. doi: 10.1111/1346-8138.17049. Epub 2023 Dec 17.